Ann: SSH: FIN: SSH Notice - Silverlake HGH Limited

• Release Date: 31/03/15 12:22
• Summary: SSH: FIN: SSH Notice - Silverlake HGH Limited
• Price Sensitive: No
• Download Document  4.23KB

					FIN
31/03/2015 12:22
SSH
NOT PRICE SENSITIVE
REL: 1222 HRS Finzsoft Solutions Limited

SSH: FIN: SSH Notice - Silverlake HGH Limited

Disclosure of movement of 1% or more in substantial holding
or change in nature of relevant interest, or both
Sections 277 and 278, Financial Markets Conduct Act 2013

To NZX Limited
and
To Finzsoft Solutions Limited ("Finzsoft")

Relevant event being disclosed: Change in nature of relevant interest and
movement of 1% or more in substantial holding
Date of relevant event:  30 March 2015
Date this disclosure made: 31 March 2015
Date last disclosure made: 26 March 2015

Substantial product holder(s) giving disclosure
Full name: Silverlake HGH Limited ("Silverlake HGH")

Summary of substantial holding
Class of quoted voting products: Ordinary shares in Finzsoft (NZX:FIN)

Summary for: Silverlake HGH
For this disclosure,--
(a) total number held in class: 7,528,990
(b) total in class: 8,566,164
(c) total percentage held in class:  87.892%
For last disclosure,--
(a) total number held in class: 6,622,940
(b) total in class: 8,566,164
(c) total percentage held in class:  77.315%
Details of transactions and events giving rise to relevant event
On 27 February 2015, Silverlake HGH made a full takeover offer for all of the
ordinary shares and other equity securities in Finzsoft (the "Offer"). The
Offer price for the ordinary shares in Finzsoft is $3.00 per share. Under the
Offer, legal and beneficial ownership to shares which are accepted into the
Offer transfers to Silverlake HGH on payment for those shares. A copy of the
Offer document was sent to NZX on 27 February 2015.  The Offer closed at
11.59pm on 30 March 2015.
Since the last disclosure dated 26 March 2015, Silverlake HGH has received
additional acceptances to the Offer for a further 906,050 ordinary shares in
Finzsoft.
On 30 March 2015, Silverlake HGH purchased 12,221 ordinary shares in Finzsoft
under the Offer, and therefore became the legal and beneficial owner of those
12,221 ordinary shares.
As at the time of this notice, Silverlake HGH has a relevant interest in
7,528,990 ordinary shares in Finzsoft (representing 87.892% of all of the
ordinary shares in Finzsoft) as follows:
- 6,622,940 ordinary shares (representing 77.315% of all of the
ordinary shares in Finzsoft), being shares which are legally and beneficially
owned by Silverlake HGH; and
- 906,050 ordinary shares (representing 10.577% of all of the ordinary
shares in Finzsoft), being shares for which Silverlake HGH has received
acceptances to the Offer, but which have not yet been paid for under the
Offer ("Acceptance Shares").
Details after relevant event
Details for: Silverlake HGH
Nature of relevant interest(s):  Registered holder and beneficial
owner of ordinary shares in Finzsoft
For that relevant interest,--
(a) number held in class: 6,622,940
(b) percentage held in class: 77.315%
(c) current registered holder(s): Silverlake HGH
(d) registered holder(s) once
transfers are registered: Not applicable
Details after relevant event
Details for: Silverlake HGH
Nature of relevant interest(s):  Power to control the acquisition of
ordinary shares in Finzsoft, on payment of the Offer price for those shares
For that relevant interest,--
(a) number held in class: 906,050
(b) percentage held in class: 10.577%
(c) current registered holder(s): Various
(d) registered holder(s) once
transfers are registered: Silverlake HGH
Additional information
Address of substantial product holder: 26-01/04, 143 Cecil Street, GB
Building, Singapore 069542
Contact details: Kwong Yong Sin
+603 7721 6118
[email protected]
Name of any other person believed to have given, or believed to be required
to give, a disclosure under the Financial Markets Conduct Act 2013 in
relation to the financial products to which this disclosure relates:
- Rubik Financial Limited
- HGH (ICT Investments No. 2) Limited and Silverlake Axis Ltd. (in each
case, on Silverlake HGH acquiring legal and beneficial title to the
Acceptance Shares).

Certification
I, Nathanael William Starrenburg, certify that, to the best of my knowledge
and belief, the information contained in this disclosure is correct and that
I am duly authorised to make this disclosure by all persons for whom it is
made.
End CA:00262539 For:FIN    Type:SSH        Time:2015-03-31 12:22:26